[1]
2025. Computational Drug Repurposing for The Management of Pathogenicity of Beta-Thalassemia. INTERNATIONAL JOURNAL OF APPLIED AND CLINICAL RESEARCH. 3, 2 (Jun. 2025), 12–19.